What is the procedure to order a test for West Nile virus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order a Test for West Nile Virus

Order serologic testing for WNV-specific IgM and IgG antibodies in serum, and if neuroinvasive disease is suspected, also test cerebrospinal fluid (CSF) for IgM antibodies. 1, 2

Primary Testing Approach

Standard Serologic Testing

  • Order IgM and IgG antibody testing on serum as the first-line diagnostic test for suspected WNV infection 1, 2
  • IgM antibodies become detectable 3-8 days after symptom onset and typically persist for 2-3 months, though they may remain positive for up to 12 months 1, 2
  • Request both acute and convalescent sera (collected 7-10 days apart) to demonstrate seroconversion, which strongly suggests recent WNV infection 1, 2

Specimen Collection and Transport

  • Collect serum in a clot tube or serum separator tube (SST) and transport at room temperature within 2 hours 1
  • For CSF testing, collect in a sterile tube and transport at room temperature within 2 hours 1

When to Add CSF Testing

Order CSF IgM antibody testing when patients present with meningitis, encephalitis, acute flaccid paralysis, or other signs of neuroinvasive disease. 2, 3

  • Detection of IgM antibodies in CSF indicates CNS infection, as IgM does not naturally cross the blood-brain barrier 1, 3
  • Be aware that traumatic lumbar puncture or disrupted blood-brain barrier can cause false-positive CSF IgM results 1

Special Testing Situations

Immunocompromised Patients

Order nucleic acid amplification testing (NAAT/PCR) in addition to serology for immunocompromised patients, as they have delayed immune responses and prolonged viremia 1, 2

  • Collect plasma (EDTA or plasma preparation tube) or serum (SST) and transport at room temperature within 2 hours 1
  • NAAT is more sensitive than serology in patients with hematologic malignancies, solid organ transplants, or those receiving B-cell-depleting antibodies 4

Pregnant Women

  • Do not screen asymptomatic pregnant women for WNV infection 2, 5
  • Test pregnant women only if they present with meningitis, encephalitis, acute flaccid paralysis, or unexplained fever in areas with ongoing WNV transmission 2, 5
  • Order both serum and CSF antibody testing in symptomatic pregnant women 2, 5

Confirmatory Testing

When Cross-Reactivity is Suspected

Request plaque reduction neutralization test (PRNT) for specimens that test positive for WNV antibodies when there is possible exposure to other flaviviruses (dengue, yellow fever, St. Louis encephalitis) or following yellow fever vaccination 1, 4

  • False-positive IgM and IgG results occur due to cross-reactivity with other flaviviruses 1
  • PRNT is also recommended for atypical presentations, deaths, or suspected unusual transmission modes like organ transplantation 4
  • Only 25% of laboratories currently have capacity to perform PRNT, so coordinate with state public health laboratories if needed 6

Interpretation Pitfalls

Avoid These Common Errors

  • Do not interpret isolated IgG positivity as acute infection—this indicates prior WNV infection and requires evaluation for alternative diagnoses 1, 2
  • Do not rely solely on serology in severely immunocompromised patients—add NAAT/PCR testing 1, 2
  • Do not order viral culture—it is insensitive and not routinely available 1

Reporting Requirements

Report all confirmed WNV infections to your state or local health department for surveillance purposes 1, 2

  • This is particularly important for pregnant women to enable tracking of pregnancy outcomes 1, 5
  • Contact CDC at 970-221-6400 for additional guidance on diagnosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach and Treatment for West Nile Virus Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

West Nile Virus Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

West Nile Virus: A Review.

JAMA, 2025

Guideline

Prevention and Management of In Utero Transmission of Vector-Borne Diseases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Laboratory testing practices for West Nile virus in the United States.

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.